Purchase Order 75N93024P00646
Award Date 5/22/24
Potential Completion Date 5/21/25
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...
- This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for $15,000.00 and does not have a set-aside designation. It provides for the delivery of Oxford Nanopore's GridION Standard Support, which includes their nanopore-based electronic systems for analyzing single molecules such as DNA, RNA, and proteins. This contract supports...
- This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $12,500.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, for a license and warranty for a GridION instrument needed to support high throughput sequencing on HERVK and HIV projects. The award has an estimated completion date of April 23, 2025. There is no set-aside designation...
- Oxford Nanopore Technologies Inc. was awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to deliver GridION software licenses. The solicitation sought GridION software or equal, including device warranty. As a foreign owned for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing systems and supplies consumables to support genomic research. They have provided equipment, reagents, kits and...
- This contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for a software license and device warranty. The $13,500.00 firm fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health (NIH). The contract will provide Oxford Nanopore's next-generation genomic sequencing products and services to support various research initiatives through February 1, 2026. Oxford Nanopore has...
- This is a $95,435 firm-fixed-price purchase order (contract) awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the supply of NANOPORE - GRIDION, a next-generation genomic sequencing platform. There is no set-aside designation associated with this award. Oxford Nanopore Technologies Inc. has...
- This is a $12,500 firm-fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS) to Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company, for a software license and warranty for a GridION system. The period of performance is from February 1, 2023, to January 31, 2024. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic sequencing equipment, consumables, reagents, software licenses, and associated services to...